An over-the-counter medication sold today as Zantac 360 by Sanofi has a different active ... Customers are turning away from the coffee giant, and its new chief executive, Brian Niccol, has ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

Boehringer Ingelheim is the exception. It has not announced any major settlements. A drug under the name of Zantac 360, which contains no ranidine, is still being currently sold.